Slow Aging and Delay Chronic Disease Development

Slow Aging and Delay Chronic Disease Development

Share this post

Slow Aging and Delay Chronic Disease Development
Slow Aging and Delay Chronic Disease Development
“Landmark Trial” of the New Cardiovascular Drug Finerenone-Not!!

“Landmark Trial” of the New Cardiovascular Drug Finerenone-Not!!

William H Bestermann Jr MD's avatar
William H Bestermann Jr MD
Aug 18, 2023
∙ Paid
34

Share this post

Slow Aging and Delay Chronic Disease Development
Slow Aging and Delay Chronic Disease Development
“Landmark Trial” of the New Cardiovascular Drug Finerenone-Not!!
11
1
Share
Evidence-based Protocol is Cheaper and More Effective

Finerenone (Kerendia) is a new drug that is prescribed to slow the progression of chronic kidney disease and the risk of cardiovascular death, non-fatal heart attack, and hospitalization for heart failure in adult patients with chronic kidney disease associated with type 2 diabetes. The retail price o…

Keep reading with a 7-day free trial

Subscribe to Slow Aging and Delay Chronic Disease Development to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 William H Bestermann Jr MD
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share